Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy

CMAJ. Canadian Medical Association Journal

Volumn 157, Issue 6, 1997, Pages 715-725

  Helewa, Michael E ^a,e   Burrows, Robert F ^b   Smith, John ^c   Williams, Keith ^d   Brain, Philippa ^c   Rabkin, Simon W ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; CANADA; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; EDEMA; EUROPE; FEMALE; FETUS OUTCOME; HUMAN; HYPERTENSION; LABORATORY TEST; MATERNAL HYPERTENSION; MEDICAL INFORMATION; MEDICAL LITERATURE; PRACTICE GUIDELINE; PROTEIN URINE LEVEL; PROTEINURIA; SPHYGMOMANOMETRY; STANDARDIZATION; UNITED STATES; WEIGHT GAIN;

EID: 9844223908     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Wittnmnn BK, Alurphy KJ, King JF, Yuen BH, Shaw D, Wittman AG. Maternal mortality in British Columbia in 1971-80. Can Mcd Assoc J 1988;139: 37-40.
2. National High Blood Pressure Education Program Working Group Report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;!63:1689-712.
3. Sibai BM. Hypertension in pregnancy. Obstet Gyncml Clin North Am 1992; I9(4):615-33.
4. Nisell H, Linter II, Luncll NO, Mollersfrom G, Pettersson E. Blood pressure and renal function seven years after pregnancy complicated by hypertension. BrJObstst Gynaecvl 1995;102:876-81.
5. Sibai BM, Taslimi MAI, el Nazer A, Amon E, Alabie EC, Ryan GAI. Alaternal perinatal outcome associated with syndrome of hemolysis, elevated liver enzymes and low platelets in severe preeclampsia-cclampsia. Am J Obstet Gynecol 1986;I55:501-9.
6. Perry KGJr, Alartin J Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin Obstet Gynccol 1992;35(2):338-50.
7. AIcKay DG. Hématologie evidence of disseminated intravascular coagulation in eclampsia. Obstet Gynecol Sum 1972;27:399-417.
8. Peek AIJ, HorvathJS, Child AG, Henderson-Smart DJ, Peat B, Gillin A. Maternal and neonatal outcome of patients classified according to the Australian Society for the Study of Hypertension in Pregnancy Consensus Statement. Med] Aast 1995;162(4):186-9.
9. Page EW, Christianson R. Influence of blood pressure changes with and without proteinuria upon outcome of pregnancy. Am J Obstet Gynecol 1976; 126:821-9.
10. Management of preeclampsia./I COG Tech Ball 1986;Feb(no 91).
11. Hypertension in pregnancy. ACOG Tech Bull 1996Jan(no 219).
12. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Clin Exp Hypertens B 1986;5(1):97-133.
13. World Health Organization Study Group. The hypertensive disorders of pregnancy, no 758 of Technical reparu series. Geneva: The Organization; 1987.
14. Sibai B. Pitfalls in diagnosis and management of preeclampsia. Am J Obstet Gynecol 1988; 159:1-5.
15. Redman CWG, Jefferies AI. Revised definitions of preeclampsia. Lancet 1988; 9:809-12.
16. Cunningham FG, Lindheimer AI. Hypertension in pregnancy. N Eng J Med 1991;326:927-32.
17. AlacGillivray I, Rose GA, Rowe D. Blood pressure survey in pregnancy. Clin Sei 1969;37:395-407.
18. Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL. Report of the Canadian Hypertension Society Consensus Conference: I. Introduction. Can MedAssocJ 1993;I49:289-93.
19. Davey DA, AlacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. AtaJOtstet Gynecol 1988;158:892-8.
20. Aloutquin JAI, Rainville C, Giroux L, Raynauld P, Bilodeau R, Amyot G, et al. Is a threshold increase in blood pressure predictive of preeclampsia? A prospective cohort study, Clin Exp Hypertens B 1990;9(2):225-35.
21. Sibai BAI. Diagnosis and management of chronic hypertension in pregnancy. Obstet Gynecol 1991;78:451-61.
22. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation. A randomized trial. Obstet Gynecol 1991;76:1070-5.
23. Fenakel K, Fenakel G, Appleman Z, Lurie S, Katz Z, Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991;77:331-7.
24. Pattinson RC, Odendaal HJ, Dutoit R. Conservative management of severe proteinuric hypertension before 28 weeks' gestation. S Afr Med J I988;73: 516-8.
25. Sibai BA1, Taslimi M, Abdella TN, Brooks TF, Spinnato JA, Anderson GD. Alaternal and perinatal outcome of conservative management of severe preeclampsia in mid-trimester. Am J Obstet Gynecol 1985;I52:32.
26. Peek AI, Shennan A, Ilalligan AIA, Lambert PC, Taylor DJ, DeSwiet AI. Hypertension in pregnancy: which method of blood pressure measurement is most predictive of outcome? Obstet Gynecol 1996;88:I030-3.
27. Visser W, Wallenburg IICS. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 1991;I7:1072-7.
28. Easterling TR, Watts H, Schmucker BC, Benedetti TJ. Aleasurement of cardiac output during pregnancy: validation of Doppler technique and clinical observations in preeclampsia. Obstet Gynecol 1987;69:845-50.
29. Easterling TR, Benedetti TJ, Schmucker BC, Alillard SP. Alaternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gym-re/1990;76:1061-9.
30. Kuzniar J, Piela A, Skret A, Palczak R, Splawinski J, Michna AI. Hemodynamic profile of mild pregnancy-induced hypertension. Clin Exp Hypertens B 1992;! 1:131-46.
31. Chesley LC, Sibai BM. Clinical significance of elevated mean arterial pressure in second trimester. Am J Obstet Gynecol 1988;159:275-9.
32. Conde-Agudelo A, Lede R, Belizan J. Evaluation of methods used in the prediction of hypertensive disorders of pregnancy. Obstet Gynecol Surv 1994; 49(3):210-22.
33. Kyle P,M, Clark SJ, Buckley D, Kissane J, Coats AJS, DeSwict M, et al. Second trimester ambulatory blood pressure in nulliparous pregnancy: A useful screening test for preeclampsia? BrJ Obstet Gynecol 1993; 100:914-9.
34. Nelson TR. A clinical study of preeclampsia. J Obstet Gynaecol Br Empire 1955;62:48-66.
35. Friedman EA. Blood pressure, edema and proteimiria in pregnancy. Amsterdam: Elsevier, 1976:279.
36. Retzke U, Graf H. Incidence of hypertension in pregnancy in relation to the definition of hypertension [in German]. Zcntralbl Gynakol 1994;116(2):73-5.
37. Helewa M, Heaman M, Robinson MA, Thompson L. Community-based home care program for the management of pre-eclampsia: an alternative. Can MedAssocJ 1993;149:829-34.
38. Shennan All, Kissane J, DeSwiet M. Validation of Spacelabs 90207 ambulatory blood pressure monitor for use in pregnancy. BrJ Obstet Gynaecol 1993; 100:904-8.
39. Marx GK, Schwalbe SS, Cho E. Automated blood pressure measurements in labouring women: Arc they reliable? Am J Obstet Gynecol 1993;168:796-8.
40. Franx A, Van der Post JAM, Elfering IM, Veerman DP, Merkus IIM, Boer K, et al. Validation of automated blood pressure recording in pregnancy. Br J Obstet Gynaecol 1994;!01:66-9.
41. Wichman K, Ryden G, WichmanM. The influence of different positions and Korotkoff sounds on die blood pressure measurements in pregnancy. Acta Obstet Gynecol Scand Suppl 1984;! 18:25-8.
42. VillarJ, Repke J, Markush L, Calvert W, Rhoads G. The measuring of blood pressure during pregnancy. ArnJObstet Gynecol I989;161:1019-24.
43. Johenning AR, Barron WAI. Indirect blood pressure measurement in pregnancy: Korotkoff phase 4 versus phase 5. Am J Obstet Gynecol 1992;167:577-80.
44. Brown MA, Reiter L, Smith B, Buddle ML, Morris R, Whitworth JA. Measuring blood pressure in pregnant women: a comparison of direct and indirect methods. Am J Obstet Gynecol 1994;171:661-7.
45. Perry IJ, Stewart BA, Brockwell J, Khan M, Davies P, Beevers DG, et al. Recording diastolic blood pressure in pregnancy. Z?A/J 1990;301:1198.
46. Brown MA, Whi worth JA. Recording diastolic blood pressure in pregnancy. BA/7199I;303:120-1.
47. Shennan A, Gupta M, Halligan A, Taylor D, DeSwiet M. Lack ofreproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry. Lancet 1996;347:139-42.
48. Gallery EDM, Brown MA, Ross MR, et al. Accuracy of indirect sphygmomanometry in determination of arterial pressure during pregnancy. In: Proceedings of the International Society for the Study of Hypertension in Pregnancy IXtb Congress, Sydney, Australia, Mar 15-lg, 1994. Monocello (NY): Dekker, 1994:74.
49. Lopez MC, Belizan JM, Villar J, Bergel E. The measurement of diastolic blood pressure during pregnancy: Which Korotkoff phase should be used? Am J Obstet Gynecol 1994;170:574-8.
50. Kuo VS, Koumantakis G, Gallery EDM. Proteinuria and its assessment in normal and hypertensive pregnancy. Am J Obstet Gynecol 1992;167:723-8.
51. Dexter L, Weiss S. Preeclampsia and eclamptic toxemia in pregnancy. Boston: Little Brown; 1941:22.
52. Friedman EA, Neff RK. Pregnancy hypertension: a systematic evaluation of clinical diagnostic criteria. Littleton (MA): P.S.G. Publishing; 1977.
53. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 1984;I48:951-63.
54. Cunningham FG, Lowe T, Guss S, Alason R. Erythrocyte morphology in women with severe preeclampsia and eclampsia. Am J Obstet Gynecol 1985; 153:358-63.
55. Gibson B, Hunter D, Naeme PB, Kelton JG. Thrombocytopenia in preeclampsia and eclampsia. Semin Tbronib lleinost 1982;8:234-47.
56. Giles C, Inglis TCAI. Thrombocytopenia and macrocytosis in gestational hypertension. BrJ Obstet Gynaecol 1981 ;88:1115-9.
57. Fay RA, Hughes AO, Farron NT. Platelets in pregnancy: hyperdestruction in pregnancy. Obstet Gynecol 1984;6I:238-40.
58. Burrows RF, I lunter DJ, Andrew M, Keldon J. A prospective study investigating the mechanism of thrombocytopenia in preeclampsia. Obstet Gynecol 1987;70:334-8.
59. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and Iow platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gymro/1982;I42:159-67.
60. Fay RA, Bowman DR, Brooks JA, Gebski V}. Platelets and uric acid in the prediction of preeclampsia./!/ J Obstet Gyiiecol 1985;152:1038-9.
61. Martin J, Blake PG, Lowry SC, Perry KG, Files JC, Morrison JC. Pregnancy complicated by preeclampsia/eclampsia with syndrome of hemolysis, elevated liver enzymes, and low platelet count: I low rapid is postpartum recovery? Obstet Gynecol 1990;76:737-4I.
62. Romero R, Alazor Al, Lockwood CJ, Emamian AI, Belanger KP, IlobbinsJC, et al. Clinical significance, prevalence and natural history of thrombocytopc nia in pregnancy induced hypertension. AmJPerinat 1989;6(l):32-38.
63. Kitzmiller JL, Lang JE, Yelcnosky PF, Lucas WE. I lematologic assays in preeclampsia. Am J Obstet Gynecol 1974;I18:362-7.
64. Pritchard JA, Cunningham FG, Alason RA. Coagulation changes in eclampsia: their frequency and pzuiogcncsis. Am J Otstet Gynecol 1976;! 24:855-64.
65. Proietti AB, Johnson AIJ, Proietti FA, RepkeJT, Bell W. Assessment of fibrin degradation products in prceclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-based agglutination. Obstet Gynecol 1991;77:696-700.
66. Weiner CP, Brandt J. Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia/eclampsia. Am J Obstet Gynecol 1982;132:27 5-81.
67. Weenink Gil, Borm JW, Ten Gate PE. Antithrombin III levels in normotcnsive and hypertensive pregnancy. Gynecol Obstet lirfest 1983;16:230-42.
68. Saleh AA, Bottoms SS, Welch RA, Ali AIA, Alariona FG, Alammen EF. Preeclampsia delivery: hemostatic system. Am] Obstet Gynecol 1987; 157:331 -6.
69. Trofatter KFJr, Howell AIL, Greenberg CS, Haye AIL. Use of fibrin Ddimer in screening for coagulation abnormalities in preeclampsia. Obstet GyUOT/1989;73:435-40.
70. Thornton CA, Bonnar J. Factor VIII related antigen and factor VIII coagulant activity in normal and preeclamptic pregnancy. BrJ Obstct Gynaecol 1977; 84:919-23.
71. Reinthaller A, AIursch-Edlmayr G, Tatra G. Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery. BrJ Obstet Gynaccol 1990;97:506-IO.
72. Hill LAI. Aletabolism of uric acid in nomral and toxcmic pregnancy. Mayo C//nßwl978;53:743-51.
73. Sagen N, I laram K, Nilsen ST. Serum urate as a predictor of fetal outcome in severe preeclampsia. Acta Obstet GynecolScand 1984;63:71-5.
74. Gaber LW, Spargo BII, Lindheimer AID. Renal pathology in preeclampsia. Clin Obstct Gynecol 1987;l:971-95.
75. Grant AAI, Elbourne DR, Valentin L, Alexander S. Routine formal fetal movement counting and the risk of antcpartum late death in normally formed singletons. Lancet 1989;II:345-9.
76. Brown VA, Sawers RS, Parsons RJ, Duncan SLB, Cooke ID. The value of antenatal cardiotocography in the management of high-risk pregnancy: a randomized controlled trial. BrJ Obstet Gynaecol 1982;89:716-22.
77. Flynn AAI, Kelly J, Alansfield H, Needham P, O'Connor AI, Viegas O. A randomized controlled trial of non-stress antepartum cardiotocography. BrJ Obstet Gynaecol 1982;89:427-33.
78. Lumley J, Lester A, Anderson I, Renou P, Wood C. A randomized trial of weekly cardiotocography in high-risk obstetric patients. Br J Obstet Gynaecol 1983;90:1018-26.
79. Kidd LC, Patel NB, Smith R. Non-stress antenatal cardiotocography - a prospective randomized clinical trial. BrJOktet Gyvaecol 1985;92:1156-9.
80. Manning FD, Lange IR, Morrison I, Harman CR. Fetal biophysical profile score and the non-stress test: a comparative trial. Obstet Gynecol 1984;64:326-31.
81. Platt LD, WalIa CA, Paul RH, Trujillo ME, Loesser CV, Jacobs ND, et al. A prospective trial of the fetal biophysical profile versus the nonstress test in the management of high-risk pregnancies. AmJ Obstet Gynecol 1985; 153:624-33.
82. Almstrom H, Axelsson O, Cnattinguis S, Ekman G, Maesel A, Ulmsten U, et al. Comparison of umbilical artery velocimetry and cardiotocography for surveillance of small-for-gestational-age fetuses. A multicenter randomized controlled atria! [zbsmct]. J Matern Fetal Invest 199I;1:127.
83. Hofmyer GJ, Partinson R, Buckley D, Jcnnings J, Redman CVVG. Umbilical artery resistance index as a screening test for fetal well-being. II. Randomised feasibility study. Otstet Gynccol 199i;78:359-62.
84. AlcParland P, Pearce JM. Doppler blood flow in pregnancy [review]. Placenta 1988;9(4):427-50.
85. Newnham JP, O'Dea AIRA, Reid KP, Dicpevecn DA. Doppler flow velocity waveform analysis in high-risk pregnancies: a randomised controlled trial. Br J Obstet Gynascol 1991;98:956-63.
86. Trudinger BJ, Cook CM, Giles WB, Connelly A, Thompson RS. Umbilical artery flow velocity waveforms in high-risk pregnancy. A randomised controlled trial. Lancet 1987;1:I88-90.